Impact of extracellular nuclease production on the biofilm phenotype of Staphylococcus aureus under In vitro and In vivo conditions

Infection and Immunity

Volumn 80, Issue 5, 2012, Pages 1634-1638

  Beenken, Karen E ^a   Spencer, Horace ^a   Griffin, Linda M ^a   Smeltzer, Mark S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; NUCLEASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BIOFILM; ENZYME SYNTHESIS; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETER-RELATED INFECTIONS; DAPTOMYCIN; DEOXYRIBONUCLEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MICROBIAL SENSITIVITY TESTS; MUTATION; STAPHYLOCOCCUS AUREUS;

EID: 84859822453     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06134-11     Document Type: Article

References (24)

1. Beenken KE, Blevins Smeltzer JSS. 2003. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect. Immun. 71:4206-4211.
2. Beenken KE, et al. 2004. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186:4665-4684.
3. Beenken KE, et al. 2010. Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One 5:e10790.
4. Berends ET, et al. 2010. Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J. Innate Immun. 2:576-586.
5. Fitzpatrick F, Humphreys H, O'Gara JP. 2005. The genetics of staphylococcal biofilm formation-will a greater understanding of pathogenesis lead to better management of device-related infection? Clin. Microbiol. Infect. 11:967-973.
6. Geoghegan JA, et al. 2010. Role of surface protein SasG in biofilm formation by Staphylococcus aureus. J. Bacteriol. 192:5663-5673.
7. Günther F, et al. 2009. Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol. Immunol. 46:1805-1813.
8. Houston P, Rowe SE, Pozzi C, Waters EM, O'Gara JP. 2011. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect. Immun. 79:1153-1165.
9. Huseby MJ, et al. 2010. Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc. Natl. Acad. Sci. U. S. A. 107: 14407-14412.
10. John AK, Schmaler M, Khanna N, Landmann R. 2011. Reversible daptomycin tolerance of adherent staphylococci in an implant infection model. Antimicrob. Agents Chemother. 55:3510-3516.
11. Kiedrowski MR, et al. 2011. Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLoS One 6:e26714.
12. Mack D, et al. 2004. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int. J. Med. Microbiol. 294:203-212.
13. Mann EE, et al. 2009. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS One 4:e5822.
14. O'Gara JP. 2007. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol. Lett. 270:179-188.
15. O'Neill E, et al. 2008. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J. Bacteriol. 190:3835-3850.
16. Pilsczek FH, et al. 2010. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 185:7413-7425.
17. Ranjit DK, Endres JL, Bayles KW. 2011. Staphylococcus aureus CidA and LrgA proteins exhibit holin-like properties. J. Bacteriol. 193:2468-2476.
18. Rice KC, Bayles KW. 2008. Molecular control of bacterial death and lysis. Microbiol. Mol. Biol. Rev. 72:85-109.
19. Rice KC, et al. 2007. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 104:8113-8118.
20. Speziale P, et al. 2008. Prevention and treatment of Staphylococcus biofilms. Curr. Med. Chem. 15:3185-3195.
21. Tang J, et al. 2011. The staphylococcal nuclease prevents biofilm formation in Staphylococcus aureus and other biofilm-forming bacteria. Sci. China Life Sci. 54:863-869.
22. Tsang LH, Cassat JE, Shaw LN, Beenken KE, Smeltzer MS. 2008. Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS One 3:e3361.
23. Weiss EC, Spencer HJ, Daily SJ, Weiss BD, Smeltzer MS. 2009. Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheterassociated in vitro model of biofilm formation. Antimicrob. Agents Chemother. 53:2475-2482.
24. Weiss EC, et al. 2009. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo. Antimicrob. Agents Chemother. 53:4096-4102.